The Bloomberg BNA Intellectual Property Blog is the home of the "Do You Copy?" podcast and offers links to selected articles by the BNA IP team, which is accessible to both subscribers and non-subscribers as well as commentary and analysis exclusive to this blog.
Thursday, June 20, 2013
by Tony Dutra
Bloomberg BNA full story:
Tamlin H. Bason and Tony Dutra's writeup of the Supreme Court's 5-3 decision June 17 that drug firms' pay-for-delay deals may violate antitrust laws, appearing in BNA's Patent, Trademark & Copyright Law Daily (accessible to both subscribers and non-subscribers).
You must Sign In or Register to post a comment.
Stakeholders hopeful open approach bodes well for Goodlatte's copyright reform efforts
Asian-American rock band's attempt to register 'The Slants' rejected under §2(a)
Goodlatte's second draft on anti-troll legislation drops, adapts provisions
Todd Hughes to Join Federal Circuit following Senate's 98-0 confirmation vote
FTC seeks comments on questions to ask patent assertion entities under 6(b) authority